Skip to main content
. 2011 Nov 25;11:496. doi: 10.1186/1471-2407-11-496

Figure 6.

Figure 6

Specific survival (cancer-related death) probability according to CCND1 A870G gene polymorphism in the whole population. Median survival was 9.9 months in AA patients (8 patients, 6 events) vs 9.0 months in AG patients (35 patients, 25 events) vs 4.7 months in GG patients (12 patients, 11 events); Log Rank test: p = 0.050. Comparison of AA+AG patients (median survival 9.0 months) vs GG patients gave a p value at 0.015.